Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Alleviate Dexamethasone-Induced Myotube Atrophy by Regulating Mitophagy via the PINK1 Signaling Pathway

As people age, their muscles naturally shrink and weaken, a condition known as sarcopenia. This decline is not just about losing strength; it is a complex breakdown of the body's internal machinery. Inside every muscle cell, tiny structures called mitochondria act as power plants, generating the energy needed for movement and repair. When these power plants become damaged or inefficient, they stop producing enough energy and begin leaking harmful byproducts that poison the cell. To survive, cells have a built-in recycling system that identifies these broken power plants, removes them, and replaces them with fresh ones. However, in aging muscles, this cleaning process often fails, leading to a buildup of damaged components and a rapid loss of muscle mass. Finding a way to restart this cellular cleanup crew is a major goal for researchers hoping to treat muscle wasting.

In a recent study published in September 2026, scientists at Xi'an Honghui Hospital investigated whether a specific type of biological messenger could help repair this damage. They focused on exosomes, which are tiny, bubble-like sacs released by bone marrow stem cells. These sacs act as delivery vehicles, carrying proteins and genetic instructions from one cell to another to coordinate healing and growth. The researchers wanted to see if these exosomes could rescue muscle cells that were being forced to waste away. To test this, they created a controlled laboratory model using mouse muscle cells that had been treated with a chemical known to mimic the muscle-wasting effects of certain medications and aging. This chemical, dexamethasone, causes the cells to shrink and lose their ability to function, providing a clear stage to observe how well a treatment works.

The team first confirmed that the exosomes they collected were the right size and contained the correct markers to be considered genuine delivery vehicles. They then exposed the shrinking muscle cells to these exosomes. The results were immediate and significant. The treated cells, which were previously struggling to survive, began to regain their vitality. They produced more energy, their internal power plants became more stable, and the dangerous levels of toxic byproducts that had been accumulating inside them dropped sharply. Most importantly, the cells stopped breaking down their own structural proteins, a process that usually leads to muscle loss. The researchers observed that the treated cells looked healthier and maintained their shape much better than the untreated, shrinking cells.

To understand exactly how this rescue happened, the scientists looked deeper into the cellular machinery. They discovered that the exosomes triggered a specific signaling pathway known as PINK1. Under normal circumstances, this pathway acts as a sensor for damaged power plants. When the exosomes arrived, they switched this sensor on, which in turn activated a cleanup crew. This crew began to identify the broken mitochondria, wrap them up, and dispose of them efficiently. The study showed that the treated cells were much better at clearing out their damaged components and replacing them with healthy ones. This process, known as mitophagy, restored the balance of energy and health within the muscle cells, effectively alleviating the wasting effect caused by the chemical treatment.

The researchers were careful to prove that this cleanup process was the actual cause of the improvement, rather than just a side effect. They introduced a substance that specifically blocks the cellular recycling system. When they added this blocker to the treated cells, the benefits of the exosomes disappeared. The cells could no longer clear out their damaged power plants, and they returned to a state of decline. This crucial step confirmed that the exosomes worked specifically by turning on the PINK1 pathway to restart the cleaning process. Without this specific mechanism, the treatment had no effect, proving that the restoration of the recycling system was the key to saving the muscle cells.

The study also measured the levels of specific proteins that signal muscle loss. In the untreated, shrinking cells, these loss signals were high, and the proteins responsible for building muscle were low. After treatment with the exosomes, the signals for muscle loss dropped, and the proteins needed for muscle strength increased. The cells not only survived but began to function more like healthy muscle tissue again, though the researchers noted this was a partial amelioration of the damage in the laboratory setting. The researchers noted that while these results were obtained in a laboratory setting using mouse cells, they offer a promising new direction for understanding how to treat muscle wasting. The findings suggest that using these tiny biological delivery vehicles could be a way to restore the health of aging muscles by fixing their internal power plants and cleaning up the cellular debris that causes them to fail.

This work highlights a potential shift in how scientists might approach muscle degeneration. Instead of trying to force muscles to grow through exercise or nutrition alone, which can be difficult for frail or elderly individuals, this approach targets the root cause of the damage at the cellular level. By delivering the right instructions to restart the body's natural cleaning and repair systems, it may be possible to halt or even reverse the wasting process. The study concludes that these exosomes, derived from bone marrow stem cells, hold significant promise as a treatment strategy. They offer a way to clear out the damaged components that accumulate with age and restore the energy balance necessary for muscle health, providing a new, cell-free tool that could one day help people maintain their strength and independence as they grow older.